A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Clinical trial NCT00887159 · COMPLETED

Trial details

NCT number: NCT00887159
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Carcinoma Recurrent Small Cell Lung Carcinoma

Start date: 2009-07-16
Primary completion: 2016-11-15
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.